Evidence map›Paper›PMID 40028729›Full record

ArticleEuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology2025

A propensity-matched comparison of plug- versus suture-based vascular closure after TAVI.

David Grundmann, Won Kim, Caroline Kellner, Matti Adam, Daniel Braun, Alexander R Tamm, Max Meertens, Christian W Hamm, Sabine Bleiziffer, Jonas Gmeiner and 24 more

Abstract readComparative StudyMulticenter Study
In one paragraph

Article in EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Routine versus selective use of a femoral protection wire in transfemoral TAVI: a single-centre analysis of vascular complications.Clinical research in cardiology : official journal of the German Cardiac Society · 2026
    Article
  2. Ultrasound versus angiographic guided access in transfemoral TAVI: intra-operator evaluation of vascular and bleeding complications.Clinical research in cardiology : official journal of the German Cardiac Society · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Access site closure after TAVI: invincible sutures.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors.

David GrundmannDepartment of Cardiology, University Heart & Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Won KimAbteilung Kardiologie/Kardiochirurgie, Kerckhoff-Klinik GmbH, Herz und Thorax Zentrum, Bad Nauheim, Germany.
Caroline KellnerDepartment of Cardiology, University Heart & Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Matti AdamUniversity Hospital Cologne - Heart Center, Klinik III für Innere Medizin - Kardiologie, Pneumologie und internistische Intensivmedizin, Cologne, Germany.
Daniel BraunMedizinische Klinik und Poliklinik I, Klinikum der Universität München, Munich, Germany.
Alexander R TammZentrum für Kardiologie - Kardiologie I, Universitätsmedizin Mainz, Mainz, Germany.
Max MeertensUniversity Hospital Cologne - Heart Center, Klinik III für Innere Medizin - Kardiologie, Pneumologie und internistische Intensivmedizin, Cologne, Germany.
Christian W HammAbteilung Kardiologie/Kardiochirurgie, Kerckhoff-Klinik GmbH, Herz und Thorax Zentrum, Bad Nauheim, Germany.
Sabine BleizifferHerz- und Diabeteszentrum Nordrhein-Westfalen, Universitätsklinik der Ruhr-Universität Bochum, Bad Oeynhausen, Germany.
Jonas GmeinerMedizinische Klinik und Poliklinik I, Klinikum der Universität München, Munich, Germany.
Alexander SedaghatMed. Klinik II - Kardiologie, Universitätsklinikum Bonn, Bonn, Germany.
David LeistnerCharité - Universitätsmedizin Berlin, Campus Benjamin Franklin (CBF), Medizinische Klinik für Kardiologie, Berlin, Germany.
Matthias RenkerAbteilung Kardiologie/Kardiochirurgie, Kerckhoff-Klinik GmbH, Herz und Thorax Zentrum, Bad Nauheim, Germany.
Hendrik WienemannUniversity Hospital Cologne - Heart Center, Klinik III für Innere Medizin - Kardiologie, Pneumologie und internistische Intensivmedizin, Cologne, Germany.
Efstratios CharitosAbteilung Kardiologie/Kardiochirurgie, Kerckhoff-Klinik GmbH, Herz und Thorax Zentrum, Bad Nauheim, Germany.
Marie LinnemannMedizinische Klinik und Poliklinik I, Klinikum der Universität München, Munich, Germany.
Tobias LerchnerHelios Universitätsklinikum Wuppertal - Herzzentrum Universität Witten/Herdecke, Wuppertal, Germany.
Benjamin JuriCharité - Universitätsmedizin Berlin, Campus Benjamin Franklin (CBF), Medizinische Klinik für Kardiologie, Berlin, Germany.
Mostafa SalemKlinik für Innere Medizin III, Schwerpunkte Kardiologie, Angiologie und Intensivmedizin, Universitätsklinikum Schleswig-Holstein, Kiel, Germany.
Roman Benetti-LehmannHerz- und Diabeteszentrum Nordrhein-Westfalen, Universitätsklinik der Ruhr-Universität Bochum, Bad Oeynhausen, Germany.
Henryk DregerDepartment of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum der Charité, Campus Virchow-Klinikum, Berlin, Germany.
Alina GoßlingDepartment of Cardiology, University Heart & Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Awesta NahifDepartment of Cardiology, University Heart & Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Lenard ConradiDepartment of Cardiovascular Surgery, University Heart & Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Niklas SchoferDepartment of Cardiology, University Heart & Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Andreas SchäferDepartment of Cardiovascular Surgery, University Heart & Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Jasmin PoparaKlinik für Innere Medizin III, Schwerpunkte Kardiologie, Angiologie und Intensivmedizin, Universitätsklinikum Schleswig-Holstein, Kiel, Germany.
Misumasa SudoMed. Klinik II - Kardiologie, Universitätsklinikum Bonn, Bonn, Germany.
Smita ScholtzHerz- und Diabeteszentrum Nordrhein-Westfalen, Universitätsklinik der Ruhr-Universität Bochum, Bad Oeynhausen, Germany.
Ralph Stephan von BardelebenZentrum für Kardiologie - Kardiologie I, Universitätsmedizin Mainz, Mainz, Germany.
Marc VorpahlHelios Universitätsklinikum Wuppertal - Herzzentrum Universität Witten/Herdecke, Wuppertal, Germany.
Derk FrankKlinik für Innere Medizin III, Schwerpunkte Kardiologie, Angiologie und Intensivmedizin, Universitätsklinikum Schleswig-Holstein, Kiel, Germany.
Tanja K RudolphHerz- und Diabeteszentrum Nordrhein-Westfalen, Universitätsklinik der Ruhr-Universität Bochum, Bad Oeynhausen, Germany.
Moritz SeiffertDepartment of Cardiology, University Heart & Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVascular access site complications are associated with increased morbidity and mortality after transcatheter aortic valve implantation (TAVI). Current results comparing strategies with plug- (P-VCD; MANTA) and suture-based vascular closure devices (S-VCD; Perclose ProGlide) remain inconsistent.

aimsIt was our aim to assess the incidence of access-related vascular complications after P-VCD or S-VCD strategies after transfemoral TAVI.

methodsThe Plug or sUture based vascuLar cloSurE after TAVI (PULSE) registry retrospectively evaluated 10,120 consecutive patients who had undergone transfemoral TAVI at 10 centres from 2016 to 2021. A propensity score was used to match 900 P-VCD patients with 1,800 S-VCD patients in a 1:2 fashion. The primary outcome measures were major and minor access-related vascular complications at the primary access site, adjudicated according to Valve Academic Research Consortium 3 definitions.

resultsThe median age was 81.8 years, 46.4% of patients were female, and the median European System for Cardiac Operative Risk Evaluation II was 3.50%. In matched P-VCD and S-VCD groups, large-bore access-related complications occurred in 14.9% vs 10.3% (p<0.001; major: 3.6% vs 4.6%; p=0.218; minor: 11.3% vs 5.8%; p<0.001) of patients. Bleeding accounted for most of these complications (9.6% vs 7.2%; p=0.028) and was treated with endovascular balloon inflation (5.4% vs 2.6%; p<0.001), stent implantation (4.7% vs 0.7%; p<0.001) or surgical repair (0.7% vs 1.7%; p=0.03).

conclusionsP-VCD were associated with higher rates of primary access-related vascular complications, driven by minor complications, compared to S-VCD. Endovascular treatment was more common after P-VCD failure.

Indexed as

Suture TechniquesTranscatheter Aortic Valve ReplacementVascular Closure DevicesAgedAged, 80 and overFemaleFemoral ArteryHumansMalePropensity ScoreRegistriesRetrospective StudiesTreatment Outcome

Identifiers

PMID40028729
PMCPMC11849536

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.